Improving the lives of people with Down syndrome through advanced biomedical research
We use state-of-the-art, transformational research platforms to decipher the unique biology and disease spectrum caused by trisomy of chromosome 21.
Our ultimate goal is to enable precision medicine approaches to improve health outcomes in Down syndrome, including the development of new diagnostic and therapeutic tools.
Sie Center and University researchers investigate corneal morphology in young individuals with Down syndrome
Hyper Immune System May Be Key to Down Syndrome Symptoms
Should people with Down syndrome be considered high-risk during COVID-19? Dr. Espinosa reviews the evidence.
CU Anschutz at the forefront of breakthroughs in Down syndrome research on World Down Syndrome Day
We are the largest geographical cluster of Down syndrome researchers in the world
Comprised of over 50 Principal Investigators and countless more contributing scientists from across the University of Colorado campuses, our researchers bring expertise from a variety of fields.
Together, we are working to decipher the complex mechanisms and multi-faceted health impacts of trisomy 21.
